MedPath

Indego Exoskeleton After SCI

Not Applicable
Completed
Conditions
Spinal Cord Injury
Interventions
Device: Indego Powered Exoskeleton
Registration Number
NCT02793635
Lead Sponsor
Parker Hannifin Corporation
Brief Summary

The purpose of this study is to assess the use of Indego as a gait training tool for subjects with complete or incomplete paraplegia as a result of spinal cord injury (SCI) who have preserved lower extremity function. It is hypothesized that subjects with complete or incomplete paraplegia who have preserved their lower extremity function will experience functional improvements after gait training with the Indego exoskeleton.

Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment.

The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • 18 years or older

  • Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length)

  • Weight 250 lbs or less

  • Present with paraplegia resulting from a complete or incomplete (AIS A, B, C, or D) Spinal Cord Injury (>1 year post-injury), with preserved LE function

  • Uses wheelchair as primary means of mobility in the community

  • Able to ambulate 14 meters with assist of 2 people and no orthostasis. Subjects may use any combination of stability aids and/or bracing.

  • Medical clearance for weight bearing and locomotor training

    • Bone density exams will be at the discretion of each sites' Principle Investigator
  • Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait and use of appropriate assistive device/stability aid

  • Skin intact where interfaces with the Indego device

  • Modified Ashworth Scale 3 or less in bilateral LEs

  • Blood pressure and heart rate within Locomotor Training Guidelines

    • At rest: Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
    • Exercise: Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
Exclusion Criteria
  • Inability to meet ALL inclusion criteria
  • Currently participating in physical therapy for gait training
  • Joint contractures of the shoulders, trunk, hips knees or ankles deemed unsafe for locomotor training by PT and or MD
  • Edema that would put skin at risk for breakdown
  • Modified Ashworth Spasticity of 4
  • Inability to achieve adequate fit of the Indego device
  • Pregnancy
  • Colostomy bag

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SCI PatientsIndego Powered Exoskeleton* 10 subjects with complete or incomplete SCI (\> 1 year post-injury) with preserved LE function will be recruited. * No control group
Primary Outcome Measures
NameTimeMethod
Functional ambulation category (FAC) to measure gait quality1 Day

Categorizes patients according to basic motor skills necessary for functional ambulation

10 Meter Walking Test to measure fast gait speed1 Day

Assesses walking speed in meters per second over a short duration

6 Minute Walking test to measure endurance6 Minutes

Measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

TIRR Memorial Hermann

🇺🇸

Houston, Texas, United States

St. Charles Hospital

🇺🇸

Port Jefferson, New York, United States

Sheltering Arms

🇺🇸

Mechanicsville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath